BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Small Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2158.56 only $755.50

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,021.63
      0.57%
      US Tech 100
      20,367.60
      0.51%
      Dow Jones
      44,860.31
      0.28%
      Brent Oil
      72.365
      -0.12%
      Bitcoin
      93,201.89
      1.34%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Gilead Sciences Inc (GILD)

      7. Gilead Sciences Inc (GILD) Financials

      Gilead Sciences Inc

      Gilead Sciences Inc (GILD)

      DMG Mori AG
      DMG Mori AG
      DMG Mori AG
      DMG Mori AG
      Guild Esports Plc
      91.35
      0.86
      (0.95%)
      Closed November 27 4:00PM
      Delayed by 15 minutes
      91.76
      0.41
      (0.45%)
      After Hours: 7:56PM
      Delayed by 15 minutes

      Gilead Sciences Inc Financial Summary

      The current GILD market cap is 114.36B. The company's latest EPS is USD 4.5456 and P/E is 20.10.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 6.6B7.05B7.11B6.69B6.95B
      Operating Income 1.67B2.63B1.61B-4.32B2.64B
      Net Income 1.05B2.18B1.43B-4.17B1.61B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 22.45B24.69B27.31B27.28B27.12B
      Operating Income 4.29B4.07B9.92B7.33B7.61B
      Net Income 5.39B123M6.23B4.59B5.67B

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 62.34B62.37B62.13B56.29B53.58B
      Total Liabilities 41.24B40.13B39.38B38.84B35.38B
      Total Equity 21.09B22.24B22.75B17.46B18.2B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 61.63B68.41B67.95B63.17B62.13B
      Total Liabilities 38.98B50.19B46.89B41.96B39.38B
      Total Equity 22.65B18.22B21.06B21.21B22.75B

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 4.08B5.84B8.01B2.22B3.54B
      Investing -1.31B-1.54B-2.27B-2.21B-2.51B
      Financing -2.51B-4.03B-5.13B-1.36B-4.31B
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 9.14B8.17B11.38B9.07B8.01B
      Investing -7.82B-14.62B-3.13B-2.47B-2.27B
      Financing -7.63B770M-8.88B-6.47B-5.13B

      Stats and Ratios

      Market Cap 114.36B
      Price to Earnings Ratio 20.10
      Price to Sales Ratio 4.2
      Price to Cash Ratio 18.71
      Price to Book Ratio 5
      Dividend Yield 3.36%

      Share Statistics

      Shares Outstanding 1.25B
      Average Volume (1 week) 6.14M
      Average Volume (1 Month) 7.56M
      52 Week Change 22.17%
      52 Week High 98.90
      52 Week Low 62.07
      Spread (Intraday) 8.25 (8.73%)

      Company Info

      Company Name Gilead Sciences Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.gilead.com
      Industry biological pds,ex diagnstics (2836)